Skip to content

Practical Controlled Trial of Wearable Monitoring for Elderly Patients with Diabetes Comorbidity

Practical Controlled Trial of Wearable Monitoring for Elderly Patients with Diabetes Comorbidity

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500110540
Enrollment
Unknown
Registered
2025-10-15
Start date
2025-09-12
Completion date
Unknown
Last updated
2025-10-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Elderly diabetes with cardiovascular and cerebrovascular diseases

Interventions

Control Group:Do not wear equipment and maintain traditional health community care.
intervention group:Wear a smart ring (wear it all the time) and CGM (wear it for 14 days during the baseline period, 14 days during the intervention period, and 14 days

Sponsors

Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
60 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Patients aged >= 60 years and 50% (ICD-10: I20.801, I25.103); or patients diagnosed with ischemic stroke (ICD-10: I69.300, I63.900); 4. Whenever possible, priority for enrollment will be given to patients with FPG >= 7.0 mmol/L and = 7.0% and <= 12.0%.

Exclusion criteria

Exclusion criteria: 1. Patients who are unable to wear the smart ring or CGM; 2. Patients who are non-ambulatory or have severe cognitive impairment/dementia; 3. Patients who are unable to use a smartphone or do not have access to Wi-Fi; 4. Patients who are unable to answer subjective questionnaires; 5. Patients who do not accept the informed consent form; 6. Patients involved in medical disputes.

Design outcomes

Primary

MeasureTime frame
The proportion of patients who simultaneously meet the criteria of TIR > 70% and TBR < 4%;

Secondary

MeasureTime frame
Cognitive Function;triglyceride;blood sugar;N-terminal b-type natriuretic peptide precursor;heart rate variability, HRV;HbA1c;

Countries

China

Contacts

Public ContactLiebin Zhao

Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine

zhaoliebin@126.com+86 21 25078999

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026